What were Gaudium IVF and Women Health Ltd's latest quarterly results?
Gaudium IVF and Women Health Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: +29.4% (stable)
- Revenue Growth YoY: +12.7%
- Operating Margin: 40.1% (volatile)
Gaudium IVF and Women Health Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +30.2%AverageRe-Entry
In , Gaudium IVF and Women Health Ltd (Hospitals/Medical Services) is outperforming Nifty 500 with +30.2% relative strength. Fundamentals: Average.
Gaudium IVF and Women Health Ltd Key Facts
- PE Ratio
- 32.3x
- Market Cap
- ₹791 Cr
- PAT Growth YoY
- +29%
- Revenue Growth YoY
- +13%
- OPM
- 40.1%
- RS vs Nifty 500
- +30.2%
What's Happening
🌐FII stake decreased 2.5% this quarter
🏛️DII reducing — stake down 2.5%
💰Trading 20% below estimated fair value
Key Numbers
PAT Growth YoY
+29%
Stable
Revenue YoY
+13%
Inflection Up
Operating Margin
40.1%
+771 bps YoY
PE Ratio
32.3
Current Price
₹109
Fundamental Score
54/100
Average
3Y PAT CAGR
+20%
Market Cap
791 Cr
Valuation
Undervalued12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is Gaudium IVF and Women Health Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +13% | +33% | Inflection Up |
| PAT (Net Profit) | +29% | +20% | Stable |
| OPM | 40.1% | +771 bps | Volatile |
Other Top Hospitals/Medical Services Stocks Beating Nifty 500
Frequently Asked Questions: Gaudium IVF and Women Health Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is Gaudium IVF and Women Health Ltd's profit growing or declining?
Gaudium IVF and Women Health Ltd's profit is growing with an stable trend.
- PAT Growth YoY: +29.4% (latest quarter)
- PAT Growth QoQ: +130.3% (sequential)
- 3-Year PAT CAGR: +19.7%
- Trend: Stable — consistent growth pattern
What is Gaudium IVF and Women Health Ltd's revenue growth trend?
Gaudium IVF and Women Health Ltd's revenue growth trend is turning around (inflection up).
- Revenue Growth YoY: +12.7%
- Revenue Growth QoQ: +23.8% (sequential)
- 3-Year Revenue CAGR: +33.2%
How is Gaudium IVF and Women Health Ltd's operating margin trending?
Gaudium IVF and Women Health Ltd's operating margin is volatile.
- Current OPM: 40.1%
- OPM Change YoY: +7.7% basis points
- OPM Change QoQ: +13.3% basis points
What is Gaudium IVF and Women Health Ltd's 3-year profit and revenue CAGR?
Gaudium IVF and Women Health Ltd's long-term compounding rates
- 3-Year Profit CAGR: +19.7%
- 3-Year Revenue CAGR: +33.2%
Is Gaudium IVF and Women Health Ltd's growth accelerating or decelerating?
Gaudium IVF and Women Health Ltd's earnings growth is stable with mixed signals on a sequential basis.
- YoY Acceleration: +22.6% bps
- Sequential Acceleration: +100.0% bps
Is Gaudium IVF and Women Health Ltd overvalued or undervalued?
Gaudium IVF and Women Health Ltd appears undervalued based on our fair value analysis.
- Valuation Signal: Undervalued
- Current PE: 32.3x
- Price-to-Book: 5.2x
What is Gaudium IVF and Women Health Ltd's current PE ratio?
Gaudium IVF and Women Health Ltd's current PE ratio is 32.3x.
- Current PE: 32.3x
- Market Cap: 791 Cr
How does Gaudium IVF and Women Health Ltd's valuation compare to its history?
Gaudium IVF and Women Health Ltd's current PE is 32.3x.
- Current PE: 32.3x
- Valuation Assessment: Undervalued
What is Gaudium IVF and Women Health Ltd's price-to-book ratio?
Gaudium IVF and Women Health Ltd's price-to-book ratio is 5.2x.
- Price-to-Book (P/B): 5.2x
- Book Value per Share: ₹21
- Current Price: ₹109
Is Gaudium IVF and Women Health Ltd a fundamentally strong company?
Gaudium IVF and Women Health Ltd is rated Average with a fundamental score of 54.42/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +12.7% (10% weight)
- PAT Growth YoY: +29.4% (10% weight)
- PAT Growth QoQ: +130.3% (10% weight)
- Margins stable (10% weight)
Is Gaudium IVF and Women Health Ltd debt free?
Gaudium IVF and Women Health Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹25 Cr
What is Gaudium IVF and Women Health Ltd's return on equity (ROE) and ROCE?
Gaudium IVF and Women Health Ltd's return ratios over recent years
- FY2024: ROCE 45.0%
- FY2025: ROCE 49.0%
- FY2026: ROCE 29.0%
Is Gaudium IVF and Women Health Ltd's cash flow positive?
Gaudium IVF and Women Health Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹7 Cr
- Free Cash Flow (FCF): ₹-81 Cr
- CFO/PAT Ratio: 29% (weak cash conversion)
What is Gaudium IVF and Women Health Ltd's dividend yield?
Gaudium IVF and Women Health Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹109
Who holds Gaudium IVF and Women Health Ltd shares — promoters, FII, DII?
Gaudium IVF and Women Health Ltd's shareholding pattern (Mar 2026)
- Promoters: 71.3%
- FII (Foreign): 6.7%
- DII (Domestic): 2.6%
- Public: 19.4%
Is promoter holding increasing or decreasing in Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 71.3% (Mar 2026)
- Previous Quarter: 71.3% (Feb 2026)
- Change: 0.00% (stable)
How long has Gaudium IVF and Women Health Ltd been outperforming Nifty 500?
Gaudium IVF and Women Health Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.
Is Gaudium IVF and Women Health Ltd a new momentum entry or an established outperformer?
Gaudium IVF and Women Health Ltd is a re-entry — it briefly dropped off the outperformance list but has now returned. Re-entries can signal renewed strength.
Is Gaudium IVF and Women Health Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Gaudium IVF and Women Health Ltd may be worth studying
- Earnings growing at +29.4% YoY
- Valuation: appears undervalued
- Cash flow is positive — CFO ₹7 Cr
What is the investment thesis for Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +12.7% YoY
- Appears undervalued
What is the future outlook for Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd's forward outlook based on current data signals
- Earnings Trend: stable
- Revenue Trend: turning around (inflection up)
- Margin Trend: volatile
- Valuation: Undervalued
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.